To include your compound in the COVID-19 Resource Center, submit it here.

Taxus paclitaxel-coated stent: Pivotal; marketed in Europe and under review in the U.S

In the double-blind pivotal U.S. Taxus IV trial in 1,326 patients, the Taxus paclitaxel-coated stent met the primary

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE